Controlled extended drug release technology

• US 8,394,409 B2
• Filed: 07/01/2004
• Issued: 03/12/2013
• Est. Priority Date: 07/01/2004
• Status: Active Grant

• Current Assignee: Intellipharmaceutics Corporation (Intellipharmaceutics International, Inc.)
• Original Assignee: Intellipharmaceutics Corporation (Intellipharmaceutics International, Inc.)
• Inventors: Odidi, Isa, Odidi, Amina
• Primary Examiner(s): Heyer, Dennis
• Application Number:
  US10/880,474
• Publication Number:
  US 20060003007A1
• Time in Patent Office: 3,176 Days
• Field of Search: None
• US Class Current: 424/472
• CPC Class Codes: A61K 9/2009 Inorganic compounds
• CPC Class Codes: A61K 9/2013 Organic compounds, e.g. phospholipids, fats
• CPC Class Codes: A61K 9/2054 Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
• CPC Class Codes: A61K 9/284 obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
• CPC Class Codes: A61K 9/2866 Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Abstract

A controlled extended drug release technology for the controlled extended release of hydrophobic or hydrophilic drugs or therapeutically active agents consisting of a homogeneous blend of one or more therapeutic agents, gas generators and surrounded by one or more layers of coat made of thermoplastic water insoluble cellulose derivatives, acrylic polymers, superdisintegrants and optionally an oil, antioxidants and electrolytes. The technology platform is capable of releasing therapeutic agents via zero, first or pseudo first order release.

Claims

1. A formulation, comprising:

(a) a central compartment containing a homogeneous blend of one or more therapeutic agents, a gas generator and optionally oils, antioxidants and surface active agents;

(b) one or more tableting, extrusion and coating aids;

(c) one or more layers of coat surrounding the central compartment, the coat comprising one or more thermoplastic water insoluble cellulose ethers and esters and one or more acrylic polymers; and

(d) wherein release of therapeutic agent from said formulation is characterized by a dissolution profile in which 0.5% to 50% of the therapeutic agent is released within three hours, and greater than 50% is released in 24 hours; and

wherein the formulation is a hydrodynamically buoyant dosage form.

2. The formulation according to claim 1 wherein the cellulose ethers and esters is ethyl cellulose.

3. The formulation according to claim 1 wherein the coat further comprises one or more superdisintegrants.

4. The formulation according to claim 1 wherein the coat further comprises one or more electrolytes.

5. The formulation according to claim 4 wherein the gas generator consist of a soluble or insoluble acid source and an alkali metal carbonate.

6. The formulation according to claim 1 wherein the acrylic polymer is selected from one or a mixture of anionic polymers based on methacrylic acid esters, methacrylates copolymer and or copolymers of acrylate and methacrylates and or ethylacrylate methylmethacrylate copolymers.

7. The formulation according to claim 3 wherein the superdisintegrant is selected from one or a mixture of croscarmelose, sodium starch glycolate, and crospovidone.

8. The formulation according to claim 4 wherein the cellulose ethers and esters is ethylcellulose.

9. The formulation according to claim 4 wherein the electrolyte is chosen from one or a mixture of salts capable of providing, sodium (Na⁺), potassium (K⁺), chloride (Cl⁻

), calcium (Ca²⁺), magnesium (Mg²⁺), bicarbonate (HCO₃⁻

), phosphate (PO₄²⁻

), sulfate (SO₄²⁻

) ions.

10. The formulation according to claim 1 wherein the coat contains one or more oils.

11. The formulation according to claim 1 wherein the coat includes shellac and or Zein.

12. The formulation according to claim 10 wherein the oil is chosen from one or a mixture of animal, plant or synthetic origin.

13. The formulation according to claim 1 wherein the acrylic polymer, is chosen from one or a mixture of, methyl methacrylate copolymers, ethoxyethyl methacrylates, cyanoethyl methacrylate, aminoalkyl methacrylate copolymer, poly(acrylic acid), poly(methacrylic acid), methacrylic acid alkylamide copolyer, poly(methyl methacrylate), poly(methyl methacrylate) copolymer, polyacrylamide, aminoalkyl methacrylate copolymer, poly(methacrylic acid anhydride), and glycidyl methacrylate copolymers.

14. The formulation according to claim 1 wherein one of said one or more layers is a final top coat that is made from cellulose esters or acrylic polymers or a mixture thereof.

15. The formulation according to claim 14 wherein one of said one or more layers is a final top coat that contains a loading dose.

16. The formulation according to claim 1 wherein there is present a surface active agent.

17. The formulation according to claim 1 wherein the gas generator is an oxygen generator.

18. The formulation according to any one of claims 1 to 5, wherein the formulation is in a form selected from a tablet, a pellet, or a bead.

19. A formulation, comprising:

(a) a central compartment containing a homogeneous blend of one or more therapeutic agents, a gas generator and optionally oils, antioxidants and surface active agents;

(b) a coat surrounding the central compartment, comprising one or more thermoplastic water insoluble cellulose ethers and esters and one or more acrylic polymers and a superdisintegrant; and

(c) a loading dose top coat comprising a loading dose of a therapeutic agent;

wherein release of therapeutic agent from said formulation is characterized by a dissolution profile in which 0.5% to 50% of the therapeutic agent is released within three hours, and greater than 50% is released in 24 hours; and

wherein the formulation is a hydrodynamically buoyant dosage form.